Accuracy of left ventricular ejection fraction by contemporary multiple gated acquisition scanning in patients with cancer: comparison with cardiovascular magnetic resonance

Abstract

BackgroundMultiple gated acquisition scanning (MUGA) is a common imaging modality for baseline and serial assessment of left ventricular ejection fraction (LVEF) for cardiotoxicity risk assessment prior to, surveillance during, and surveillance after administration of potentially cardiotoxic cancer treatment. The objective of this study was to compare the accuracy of left ventricular ejection fractions (LVEF) obtained by contemporary clinical multiple gated acquisition scans (MUGA) with reference LVEFs from cardiovascular magnetic resonance (CMR) in consecutive patients with cancer.MethodsIn a cross-sectional study, we compared MUGA clinical and CMR reference LVEFs in 75 patients with cancer who had both studies within 30 days. Misclassification was assessed using the two most common thresholds of LVEF used in cardiotoxicity clinical studies and practice: 50 and 55%.ResultsCompared to CMR reference LVEFs, MUGA clinical LVEFs were only lower by a mean of 1.5% (48.5% vs. 50.0%, p = 0.17). However, the limits of agreement between MUGA clinical and CMR reference LVEFs were wide at −19.4 to 16.5%. At LVEF thresholds of 50 and 55%, there was misclassification of 35 and 20% of cancer patients, respectively.ConclusionsMUGA clinical LVEFs are only modestly accurate when compared with CMR reference LVEFs. These data have significant implications on clinical research and patient care of a population with, or at risk for, cardiotoxicity.

Impact of Cardiovascular Magnetic Resonance Imaging on Identifying the Etiology of Cardiomyopathy in Patients Undergoing Cardiac Transplantation

“…We performed a retrospective, observational study using the University of Minnesota’s Cardiovascular Magnetic Resonance Registry 14 and the Cardiac Transplantation Registry. We hypothesized that performance of pre-transplantation CMR would be associated with fewer errors.…”

Recognizing Radiation Therapy–related Complications in the Chest

“…In patients in whom this standard surveillance reveals a decrease in systolic function, with or without symptoms, cardiac MRI is the most appropriate next step (Fig 8). Compared with other imaging modalities, MRI is more accurate and repro-ducible in the measurement of cardiac function and volume and yields additional information regarding tissue characterization (51). Thus, it is considered the reference standard for assessing the myocardium for fibrosis.…”

Interpretable AI for beat-to-beat cardiac function assessment

“…In particular, left ventricular ejection fraction (EF), the ratio of left ventricular end systolic and end diastolic volume, is one of the most important metrics of cardiac function, as it identifies patients who are eligible for life prolonging therapies 8,12 . However, there can be significant interobserver variability as well as inter-modality discordance based on methodology and modality 2,5,6,[12][13][14][15] .…”